From: Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
Inhibitor type | Inhibitor | Mechanism of action (A, B or C)a | Inhibitor of Myc/Max binding to DNA in vitro | Activity in vitro | Reduction of cancer cell growth/proliferation | Tumor reduction in animal models | Reference |
---|---|---|---|---|---|---|---|
Small Molecules | IIA6B17 | B | Yes | IC50 = 50 ± 25 μM (EMSA, inhibition of E-box binding) | Yes | – | |
NY2267 | B | Yes | IC50 = 36.5 μM (EMSA, inhibition of E-box binding) | – | – | [75] | |
10,058-F4 | B | Yes | KD = 42 μM (Binding to c-Myc) 15 μM (SPR) | Yes | No | ||
10,074-G5 | B | Yes | IC50 = 146.8 μM (EMSA, inhibition of E-box binding) KD = 20 μM (Binding to c-Myc) 18 μM (SPR) | Yes | No | ||
JY-3-094 | B | Yes | IC50 = 33 μM (EMSA, inhibition of E-box binding) | Yes | – | ||
3jc48–3 | B | Yes | IC50 = 34.8 μM (EMSA, inhibition of E-box binding) | Yes | – | [86] | |
Mycro1, Mycro2 | B | Yes | IC50 = 30 ± 5 μM (Mycro1) and 23 ± 4 μM (EMSA, inhibition of dimerization and E-box binding) | Yes | – | ||
Mycro3 | B | Yes | IC50 = 40 ± 13 μM (FP competition assay, inhibition of E-box binding and dimerization) | – | Yes | ||
MYCMI-6 | B | – | KD = 1.6 ± 0.5 μM (SPR, binding to c-Myc) | Yes | Yes | [91] | |
KJ-Pyr-9 | B | Yes | KD = 6.5 ± 1.0 nM (Backscattering Interferometry, binding to c-Myc) | Yes | – | ||
MYCi361 | B, C | Yes | KD = 3.2 μM (FP competition assay, binding to c-Myc) | Yes | Yes | [94] | |
MYCi975 | B, C | – | KD = 2.5 μM (FP competition assay, binding to c-Myc) | Yes | Yes | [94] | |
Celastrol and analogues | A,C | Yes | IC50 = 67 ± 2 μM (Celastrol) (EMSA, inhibition of E-box binding) | Yes | Yes b | [95] | |
JKY-2-169 | A | Yes | IC50 = 11.6 ± 2.3 μM (EMSA, inhibition of E-box binding) | – | – | ||
EN4 | B | Yes | IC50 = 6.7 ± 2.3 μM (inhibition of E-box binding) | Yes | Yes | [98] | |
(Poly)peptide/mini-protein | Omomyc | A, B, C | Yes | KD of Omomyc homodimer = nM range (Circular Dichroism spectroscopy, binding to E-box) | Yes | Yes | |
Max bHLHZ | A, B | – | – | Yes | – | [5] | |
Mad1 | A, B | Yes | – | Yes | – | [106] | |
ME47 | A | Yes | KD = 15.3 ± 1.6 nM (EMSA, binding to E-box) | Yes c | Yes c | ||
Monoclonal antibody | B | Yes | – | – | – | [111] | |
H1 peptide | B | Yes | – | Yes | Yes | ||
aMax/aMip | B | Yes | KD = 460 μM (aMax), 250 μM (aMip) (Thermal denaturation monitored by CD, binding c-Myc in absence of DNA) | – | – | ||
Linked basic regions | A | – | – | – | – |